Acadia Healthcare (NASDAQ:ACHC) has been given a $37.00 price objective by equities researchers at Mizuho in a research note issued on Thursday. The firm currently has a “hold” rating on the stock. Mizuho’s target price would indicate a potential downside of 3.65% from the stock’s current price.

A number of other research analysts have also weighed in on ACHC. ValuEngine lowered Acadia Healthcare from a “sell” rating to a “strong sell” rating in a research note on Friday, June 29th. Zacks Investment Research raised Acadia Healthcare from a “hold” rating to a “buy” rating and set a $48.00 price target on the stock in a research note on Tuesday, July 24th. Credit Suisse Group increased their price target on Acadia Healthcare from $40.00 to $44.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 31st. Jefferies Financial Group increased their price target on Acadia Healthcare from $44.00 to $47.00 and gave the stock a “buy” rating in a research note on Tuesday, July 31st. Finally, BidaskClub lowered Acadia Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, August 1st. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $44.36.

Shares of Acadia Healthcare stock opened at $38.40 on Thursday. Acadia Healthcare has a fifty-two week low of $26.92 and a fifty-two week high of $45.27. The firm has a market cap of $3.40 billion, a price-to-earnings ratio of 16.00, a price-to-earnings-growth ratio of 1.38 and a beta of 0.63. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.24 and a current ratio of 1.24.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Monday, July 30th. The company reported $0.70 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.70. Acadia Healthcare had a return on equity of 7.93% and a net margin of 7.52%. The company had revenue of $765.70 million for the quarter, compared to analyst estimates of $767.93 million. During the same quarter in the prior year, the company posted $0.66 EPS. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. Analysts expect that Acadia Healthcare will post 2.52 earnings per share for the current fiscal year.

In other news, Director Reeve B. Waud sold 8,135 shares of the company’s stock in a transaction on Thursday, July 26th. The stock was sold at an average price of $45.00, for a total transaction of $366,075.00. Following the completion of the sale, the director now directly owns 14,213 shares in the company, valued at approximately $639,585. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 11.10% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in the company. Strs Ohio acquired a new stake in shares of Acadia Healthcare during the 3rd quarter worth $308,000. BB&T Corp increased its holdings in shares of Acadia Healthcare by 19.2% during the 3rd quarter. BB&T Corp now owns 53,180 shares of the company’s stock worth $1,872,000 after buying an additional 8,560 shares during the last quarter. Louisiana State Employees Retirement System increased its holdings in shares of Acadia Healthcare by 9.0% during the 3rd quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock worth $852,000 after buying an additional 2,000 shares during the last quarter. NJ State Employees Deferred Compensation Plan increased its holdings in Acadia Healthcare by 31.3% in the 3rd quarter. NJ State Employees Deferred Compensation Plan now owns 21,000 shares of the company’s stock valued at $739,000 after purchasing an additional 5,000 shares in the last quarter. Finally, State of New Jersey Common Pension Fund D increased its holdings in Acadia Healthcare by 22.5% in the 3rd quarter. State of New Jersey Common Pension Fund D now owns 980,000 shares of the company’s stock valued at $34,496,000 after purchasing an additional 180,000 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Read More: Short Selling Stocks and Day Traders

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.